Westpac (ASX:WBC) share price in focus on FY23 Q3 $1.8 billion profit
The Westpac Banking Corp (ASX:WBC) share price is on watch after revealing it made $1.8 billion of net profit.
Time poor? Let Rask Media’s editor-in-chief curate your daily investment news and analysis. We select the most important news of the day, plus our favourite expert stories and columns to appear in this feed.
The Westpac Banking Corp (ASX:WBC) share price is on watch after revealing it made $1.8 billion of net profit.
Welcome to this week’s 2 Sense where the Australian Property Podcast team discusses the
Sociedad Quimica y Minera de Chile (NYSE: SQM) is the world’s second-largest producer of lithium chemicals. Its 2Q23 report stunned the market by missing analyst profit expectations by ~20%, sending its shares lower.
We have so many options these days when it comes to choosing a brokerage account that it can feel impossible to make a fully informed decision, even if we’ve read all the reviews.
The Magellan Financial Group Ltd (ASX:MFG) share price has jumped 15% after the fund manager revealed its FY23 result and a special dividend.
The Telstra Group Ltd (ASX:TLS) share price is in focus after the ASX telco share announced its FY23 result to the market.
In the latest episode of ‘On the Couch’ by Marcus Today, Henry Jennings is joined by the Founder and Managing Director of Latin Resources Ltd (ASX: LRS), Chris Gale.
Over the past 5 days, the GUD Holdings Limited (ASX: GUD) share price has jumped 12.5%. But that’s no surprise to the team at Stock Doctor. Analyst Daniel Ortisi explains why this week’s news means for GUD shareholders.
The Cochlear Limited (ASX: COH) share price bounced dramatically higher this week following a bumper report. But is the Cochlear share price looking a little expensive? Stock Doctor’s Daniel Ortisi weighs in.
The Westpac Banking Corp (ASX:WBC) share price is on watch after revealing it made $1.8 billion of net profit.
Welcome to this week’s 2 Sense where the Australian Property Podcast team discusses the
Sociedad Quimica y Minera de Chile (NYSE: SQM) is the world’s second-largest producer of lithium chemicals. Its 2Q23 report stunned the market by missing analyst profit expectations by ~20%, sending its shares lower.
We have so many options these days when it comes to choosing a brokerage account that it can feel impossible to make a fully informed decision, even if we’ve read all the reviews.
The Magellan Financial Group Ltd (ASX:MFG) share price has jumped 15% after the fund manager revealed its FY23 result and a special dividend.
The Telstra Group Ltd (ASX:TLS) share price is in focus after the ASX telco share announced its FY23 result to the market.
In the latest episode of ‘On the Couch’ by Marcus Today, Henry Jennings is joined by the Founder and Managing Director of Latin Resources Ltd (ASX: LRS), Chris Gale.
Over the past 5 days, the GUD Holdings Limited (ASX: GUD) share price has jumped 12.5%. But that’s no surprise to the team at Stock Doctor. Analyst Daniel Ortisi explains why this week’s news means for GUD shareholders.
The Cochlear Limited (ASX: COH) share price bounced dramatically higher this week following a bumper report. But is the Cochlear share price looking a little expensive? Stock Doctor’s Daniel Ortisi weighs in.
Want to level-up your analytical skills and investing insights but don’t know where to start? We can help. Join 40,000+ Australian investors on our mailing list today and we’ll send you our favourite podcasts, courses, resources, investment articles and podcasts every week. Delivered to your inbox every Sunday morning. Grab a coffee and let Owen and the team bring you the best investment insights every week.
The information on this website is general financial advice only. That means, the advice does not take into account your objectives, financial situation or needs. Because of that, you should consider if the advice is appropriate to you and your needs, before acting on the information. In addition, you should obtain and read the product disclosure statement (PDS) and Target Market Determination before making a decision to acquire any financial product. If you don’t know what your needs are, you should consult a trusted and licensed financial adviser who can provide you with personal financial product advice. Please read our Terms & Conditions and Financial Services Guide before using this website.
“Rask Invest” is considered a financial product and has a Product Disclosure Statement (PDS) and Target Market Determination (TMD), issued by InvestSMART. These documents can be accessed on the Rask Invest website. Please seek professional advice before making any investment decision with respect to Rask Invest.
© Rask Australia 2024